About Spirometer Device
A spirometer device is an instrument used to measure the air capacity of the lungs. It measures the volume of air expired by the lungs and entering the apparatus. Spirometer device is used to monitor various respiratory diseases such as asthma, emphysema, and bronchitis, among others. Moreover, an incentive spirometer device can be used after the surgery, in order to keep the respiratory system healthy. It is used by patients recovering from cardiac surgeries and other related illnesses.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Despite the presence of competition and brand effect problems, due to the awareness of end-users and their demand for high end products, investors are still optimistic about this area. There will be more new investors entering into this industry in the future. The manufacturers who want to occupy the market must depend on market mechanism reform, manufacturing equipment innovation, core technology improvement and brand establishment. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Hill-Rom (United States), Vyaire Medical (United States), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (United States), Medical International Research (Italy), NDD Medical Technologies (Switzerland), Vitalograph (United Kingdom) and MidMark Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Ambisea Technology, ANA-MED, Besmed Health Business, Bionet, BTL International, Cardioline and Clarity Medical.
Segmentation Overview
AMA Research has segmented the market of Global Spirometer Device market by Type (PC-based, Portable and Table-top), Application (COPD, Asthma and Other Applications) and Region.
On the basis of geography, the market of Spirometer Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Offline will boost the Spirometer Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Spirometer Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Introduction of advanced technology like integration of cell phones with spirometers
Market Growth Drivers:
Rising geriatric population is increasing the adoption of home-based spirometer for the monitoring of chronic respiratory diseases, in turn, fueling the growth of the global spirometer market. Along with this there is rising incidences of respiratory diseases
Challenges:
Need for skilled professionals and the possibility of inaccuracy and Time required to perform the test
Restraints:
Lack of awareness among the population regarding the prevalence of various pulmonary respiratory devices
Opportunities:
Urbanization has increased the level of population, leading to the prevalence of respiratory diseases in the developed economies
Market Leaders and their expansionary development strategies
In June 2020, AireHealth, maker of an FDA-cleared portable nebulizer that pairs with a smartphone app for remote monitoring, announced the acquisition of fellow respiratory health company BreathResearch. Financial terms of the deal were not disclosed.
In 2018, Schiller AG launched the CARDIOVIT CS-200 Office ErgoSpiro system. The CARDIOVIT CS-200 Excellence ErgoSpiro system performs both pulmonary function tests and metabolic tests with diagnostic-quality 12- or 16-lead exercise ECG conveniently and accurately in a single device.
Key Target Audience
Industry Investors, Manufacturers, End User Industries, Hospitals, Clinics, and Laboratories, Traders, Distributors, and Suppliers, Government and Research Organizations, Associations and Industry Bodies and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.